Relay Therapeutics is a Cambridge, Massachusetts clinical-stage precision medicines company (NASDAQ: RLAY) using protein motion to drug historically intractable oncology and genetic-disease targets.
machine-learning molecular-dynamics computational-chemistry drug-discovery cryo-em biotechnology precision-medicine oncology apis-json nras protein-motion fabry-disease genetic-disease dna-encoded-libraries allosteric-inhibitors pi3k-alpha fgfr2 clinical-stage
-
Updated
Aug 14, 2026